Nonpharmacological therapies, like cognitive behavioral therapy (CBT), for the treatment of non-motor symptoms (NMS) in Parkinson's disease (PD) have received only little attention. Promising results derive from a few studies that examined the efficacy of individual CBT for depression and anxiety in Parkinson's disease. To date no trial has evaluated the utility of CBT group for NMS in Parkinson's disease. The aim of the present preliminary study was to observe whether CBT group therapy is useful for both NMS and motor symptoms (MS) in patients affected by Parkinson's disease. The results suggested that CBT group was effective in treating depression and anxiety symptoms and can reduce the severity of MS in patients suffering from PD
Background: The aim of this study was to evaluate the efficacy of a group Cognitive Behavioural Ther...
Parkinson’s disease (PD) is a neurodegenerative disorder most commonly associated with motor sympto...
Objective: Anxiety negatively impacts the quality of life of Parkinson’s disease (PD) patients and c...
Depression and anxiety affect up to 50% of people with Parkinson's Disease (PD) (Marsh, 2000; Murray...
Neuropsychiatric symptoms are common in Parkinson's disease (PD) and have a disproportionate impact ...
Parkinson's disease [PD] is a heterogeneous neurological disorder that is characterized by motor and...
Evidence is reviewed demonstrating that cognitive behavior therapy (CBT) is effective in the treatme...
Abstract Parkinson’s Disease (PD) is a neurological condition caused by the loss of dopamine neurons...
Background Anxiety disorders are among the most prevalent and disabling neuropsychiatric syndromes i...
Parkinson's disease (PD) is characterized by motor symptoms, but nonmotor symptoms also significantl...
Objective: The aim of the current study was to evaluate whether cognitive behavioral group therapy h...
OBJECTIVES: Anxiety is a prevalent but understudied non-motor symptom of Parkinson’s disease (PD), f...
Objective: Anxiety negatively impacts the quality of life of Parkinson’s disease (PD) patients and c...
Depression and psychosis are common psychiatric features of Parkinson’s disease that have a severe i...
Background: Anxiety disorders occur in up to 35% of patients with Parkinson's disease (PD) and have ...
Background: The aim of this study was to evaluate the efficacy of a group Cognitive Behavioural Ther...
Parkinson’s disease (PD) is a neurodegenerative disorder most commonly associated with motor sympto...
Objective: Anxiety negatively impacts the quality of life of Parkinson’s disease (PD) patients and c...
Depression and anxiety affect up to 50% of people with Parkinson's Disease (PD) (Marsh, 2000; Murray...
Neuropsychiatric symptoms are common in Parkinson's disease (PD) and have a disproportionate impact ...
Parkinson's disease [PD] is a heterogeneous neurological disorder that is characterized by motor and...
Evidence is reviewed demonstrating that cognitive behavior therapy (CBT) is effective in the treatme...
Abstract Parkinson’s Disease (PD) is a neurological condition caused by the loss of dopamine neurons...
Background Anxiety disorders are among the most prevalent and disabling neuropsychiatric syndromes i...
Parkinson's disease (PD) is characterized by motor symptoms, but nonmotor symptoms also significantl...
Objective: The aim of the current study was to evaluate whether cognitive behavioral group therapy h...
OBJECTIVES: Anxiety is a prevalent but understudied non-motor symptom of Parkinson’s disease (PD), f...
Objective: Anxiety negatively impacts the quality of life of Parkinson’s disease (PD) patients and c...
Depression and psychosis are common psychiatric features of Parkinson’s disease that have a severe i...
Background: Anxiety disorders occur in up to 35% of patients with Parkinson's disease (PD) and have ...
Background: The aim of this study was to evaluate the efficacy of a group Cognitive Behavioural Ther...
Parkinson’s disease (PD) is a neurodegenerative disorder most commonly associated with motor sympto...
Objective: Anxiety negatively impacts the quality of life of Parkinson’s disease (PD) patients and c...